Lion Point Capital, LP - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lion Point Capital, LP ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$2,270,103
+23.4%
130,6910.0%1.01%
+21.6%
Q2 2023$1,840,129
+50.6%
130,691
+15.1%
0.83%
+65.4%
Q1 2023$1,221,690
-66.9%
113,540
-67.2%
0.50%
-4.2%
Q4 2022$3,689,000
-28.2%
346,500
-27.8%
0.52%
-53.7%
Q3 2022$5,140,0000.0%480,0000.0%1.13%
+93.7%
Q2 2022$5,140,000
+7.7%
480,0000.0%0.58%
-47.2%
Q1 2022$4,771,000
+637.4%
480,000
+772.7%
1.11%
+539.9%
Q4 2021$647,000
-88.5%
55,000
-88.9%
0.17%
-83.6%
Q3 2021$5,646,000
-18.2%
495,7480.0%1.06%
-11.3%
Q2 2021$6,905,000
-24.7%
495,7480.0%1.19%
-28.5%
Q1 2021$9,176,000
+4.8%
495,7480.0%1.67%
-1.1%
Q4 2020$8,759,000
+15.3%
495,7480.0%1.69%
+1.3%
Q3 2020$7,594,000
-39.9%
495,7480.0%1.67%
-45.6%
Q2 2020$12,631,000
+64.6%
495,7480.0%3.06%
+51.3%
Q1 2020$7,674,000495,7482.02%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders